Drug Design and Discovery Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, 110 Science Place, Saskatoon, Canada.
J Pharm Pharm Sci. 2012;15(4):548-67. doi: 10.18433/j3x60d.
Cationic gemini surfactants have been studied as non-viral vectors for gene therapy. Clinical applications of cationic lipid/DNA lipoplexes are restricted by their instability in aqueous formulations. In this work, we investigated the influence of lyophilization on the essential physiochemical properties and in vitro transfection of gemini surfactant-lipoplexes. Additionally, we evaluated the feasibility of lyophilization as a technique for preparing lipoplexes with long term stability.
A gemini surfactant [12-7NH-12] and plasmid DNA encoding for interferon-γ were used to prepare gemini surfactant/pDNA [P/G] lipoplexes. Helper lipid DOPE [L] was incorporated in all formulation producing a [P/G/L] system. Sucrose and trehalose were utilized as stabilizing agents. To evaluate the ability of lyophilization to improve the stability of gemini surfactant-based lipoplexes, four lyophilized formulations were stored at 25˚C for three months. The formulations were analyzed at different time-points for physiochemical properties and in vitro transfection.
The results showed that both sucrose and trehalose provided anticipated stabilizing effect. The transfection efficiency of the lipoplexes increased 2-3 fold compared to fresh formulations upon lyophilization. This effect can be attributed to the improvement of DNA compaction and changes in the lipoplex morphology due to the lyophilization/rehydration cycles. The physiochemical properties of the lyophilized formulations were maintained throughout the stability study. All lyophilized formulations showed a significant loss of gene transfection activity after three months of storage. Nevertheless, no significant losses of transfection efficiency were observed for three formulations after two months storage at 25 ˚C.
Lyophilization significantly improved the physical stability of gemini surfactant-based lipoplexes compared to liquid formulations. As well, lyophilization improved the transfection efficiency of the lipoplexes. The loss of transfection activity upon storage is most probably due to the conformational changes in the supramolecular structure of the lipoplexes as a function of time and temperature rather than to DNA degradation.
阳离子双子表面活性剂已被研究作为基因治疗的非病毒载体。阳离子脂质/DNA 脂复合物在水制剂中的不稳定性限制了它们的临床应用。在这项工作中,我们研究了冻干对双子表面活性剂脂质体的基本物理化学性质和体外转染的影响。此外,我们评估了冻干作为制备具有长期稳定性的脂质体的技术的可行性。
使用双子表面活性剂[12-7NH-12]和编码干扰素-γ的质粒 DNA 制备双子表面活性剂/pDNA[P/G]脂质体。所有制剂均加入辅助脂质 DOPE[L],形成[P/G/L]系统。蔗糖和海藻糖被用作稳定剂。为了评估冻干提高双子表面活性剂基脂质体稳定性的能力,四种冻干制剂在 25°C 下储存三个月。在不同时间点分析制剂的物理化学性质和体外转染。
结果表明,蔗糖和海藻糖都提供了预期的稳定效果。与新鲜制剂相比,冻干后的脂质体的转染效率提高了 2-3 倍。这种效果可以归因于 DNA 压缩的改善和由于冻干/复水循环导致的脂质体形态的变化。冻干制剂的物理化学性质在整个稳定性研究中得到了维持。所有冻干制剂在储存三个月后基因转染活性均显著丧失。然而,在 25°C 储存两个月后,三种制剂的转染效率没有明显下降。
与液体制剂相比,冻干显著提高了双子表面活性剂基脂质体的物理稳定性。此外,冻干提高了脂质体的转染效率。储存过程中转染活性的丧失很可能是由于脂质体超分子结构随时间和温度的变化而发生构象变化,而不是 DNA 降解。